{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T21:27:56Z","timestamp":1789334876862,"version":"build-2803163510"},"reference-count":32,"publisher":"BMJ","issue":"12","license":[{"start":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T00:00:00Z","timestamp":1671667200000},"content-version":"unspecified","delay-in-days":21,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006388","name":"H\u00f4pitaux Universitaires de Gen\u00e8ve","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100006388","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2022,11,21]]},"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To explore the utility of extended Human Papillomavirus (HPV) genotyping to detect cervical intraepithelial neoplasia grade 2 or more (CIN2+) in a \u2018screen-and-treat\u2019 strategy for HPV-positive women in low-resource settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Prospective study of diagnostic accuracy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>The study took place in West Cameroon between September 2018 and March 2020.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>2014 women were recruited. Asymptomatic, non-pregnant women aged 30\u201349 years without history of CIN treatment, anogenital cancer or hysterectomy were eligible.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>Participants performed self-sampling for HPV testing with GeneXpert followed by visual inspection with acetic acid and Lugol\u2019s iodine (VIA) triage before treatment if required.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main outcome measures<\/jats:title>\n                    <jats:p>Liquid-based cytology, biopsies and endocervical brushing were performed in HPV-positive women as quality control. We assessed the detection rate of CIN2+ by HPV genotyping (two pools of genotypes obtained from the Xpert system, pool_1 (HPV 16, 18, 45) and pool_2 (HPV 16, 18, 45, 31, 33, 35, 52, 58)), VIA and cytology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>382 (18.2%) women were HPV-positive among which 11.5% (n=44) were CIN2+. Of those 44 participants, 41 were triaged positive by extended genotyping, versus 35 by VIA and 33 by cytology. Overall, triage positivity was of 68.4% for extended genotyping, 59.3% for VIA and 14.8% for cytology, with false positive rates of 83.4%, 84.1% and 37.7%, respectively. Extended genotyping had a higher sensitivity for CIN2+ detection (93.2%, CI: 81.3 to 98.6) than VIA (79.5%, CI: 64.7 to 90.2, p=0.034) and cytology (75.0%, CI: 59.7 to 86.8, p=0.005). No significant difference was observed in the overtreatment rate in triaged women by extended genotyping or VIA (9.9%, CI: 8.6 to 11.3, and 8.8%, CI: 7.7 to 10.1), with a ratio of 6.0 and 6.3 women treated per CIN2+ diagnosed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Triage of HPV-positive women with extended HPV genotyping improves CIN2+ detection compared with VIA with a minor loss of specificity and could be used to optimize the management of HPV-positive women.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT03757299\">NCT03757299<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2021-057234","type":"journal-article","created":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T10:05:12Z","timestamp":1671703512000},"page":"e057234","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":16,"title":["Utility of extended HPV genotyping for the triage of self-sampled HPV-positive women in a screen-and-treat strategy for cervical cancer prevention in Cameroon: a prospective study of diagnostic accuracy"],"prefix":"10.1136","volume":"12","clinical-trial-number":[{"clinical-trial-number":"nct03757299","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct05385406","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7359-7691","authenticated-orcid":false,"given":"Celine","family":"Broquet","sequence":"first","affiliation":[{"name":"Department of Paediatrics, Gynaecology and Obstetrics, Geneva University Hospitals, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Vassilakos","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Gynaecology and Obstetrics, Geneva University Hospitals, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois Marcel","family":"Ndam Nsangou","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Obstetrics and Maternal Health, University of Dschang, Dschang District Hospital, Dschang, Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Kenfack","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Obstetrics and Maternal Health, University of Dschang, Dschang District Hospital, Dschang, Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Noubom","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Obstetrics and Maternal Health, University of Dschang, Dschang District Hospital, Dschang, Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Tincho","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Obstetrics and Maternal Health, University of Dschang, Dschang District Hospital, Dschang, Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6625-3575","authenticated-orcid":false,"given":"Emilien","family":"Jeannot","sequence":"additional","affiliation":[{"name":"Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3942-2134","authenticated-orcid":false,"given":"Ania","family":"Wisniak","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Gynaecology and Obstetrics, Geneva University Hospitals, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Petignat","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Gynaecology and Obstetrics, Geneva University Hospitals, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,12,22]]},"reference":[{"key":"2025121602243053000_12.12.e057234.1","unstructured":"World Health Organization . WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention. Geneva: World Health Organization, 2013. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK195239\/"},{"key":"2025121602243053000_12.12.e057234.2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00176-14"},{"key":"2025121602243053000_12.12.e057234.3","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70188-7"},{"key":"2025121602243053000_12.12.e057234.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2012.11.020"},{"key":"2025121602243053000_12.12.e057234.5","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31261"},{"key":"2025121602243053000_12.12.e057234.6","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-19-0239"},{"key":"2025121602243053000_12.12.e057234.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2015.01.551"},{"key":"2025121602243053000_12.12.e057234.8","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPTGD94EVRSJCG"},{"key":"2025121602243053000_12.12.e057234.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2014.12.022"},{"key":"2025121602243053000_12.12.e057234.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.pvr.2016.05.004"},{"key":"2025121602243053000_12.12.e057234.11","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.22527"},{"key":"2025121602243053000_12.12.e057234.12","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70230-8"},{"key":"2025121602243053000_12.12.e057234.13","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/ijc.31326","article-title":"Human papilloma virus genotyping for the cross-sectional and longitudinal probability of developing cervical intraepithelial neoplasia grade 2 or more","volume":"143","author":"Del Mistro","year":"2018","journal-title":"Int J Cancer"},{"key":"2025121602243053000_12.12.e057234.14","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dji014"},{"key":"2025121602243053000_12.12.e057234.15","doi-asserted-by":"crossref","first-page":"e296","DOI":"10.1016\/S2214-109X(19)30527-3","article-title":"Clinical evaluation of modifications to a human papillomavirus assay to optimise its utility for cervical cancer screening in low-resource settings: a diagnostic accuracy study","volume":"8","author":"Kuhn","year":"2020","journal-title":"Lancet Glob Health"},{"key":"2025121602243053000_12.12.e057234.16","doi-asserted-by":"publisher","DOI":"10.1177\/0969141315604863"},{"key":"2025121602243053000_12.12.e057234.17","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-16-0705"},{"key":"2025121602243053000_12.12.e057234.18","doi-asserted-by":"crossref","first-page":"7293","DOI":"10.1002\/cam4.3355","article-title":"Implementing the 3T-approach for cervical cancer screening in Cameroon: preliminary results on program performance","volume":"9","author":"Levy","year":"2020","journal-title":"Cancer Med"},{"key":"2025121602243053000_12.12.e057234.19","first-page":"601","article-title":"Vingt ann\u00e9es de lutte contre le cancer du col ut\u00e9rin en Afrique subsaharienne - Collaboration m\u00e9dicale entre Gen\u00e8ve et Yaound\u00e9","volume":"15","author":"Vassilakos","year":"2019","journal-title":"Rev Med Suisse"},{"key":"2025121602243053000_12.12.e057234.20","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2020-001422"},{"key":"2025121602243053000_12.12.e057234.21","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/LGT.0000000000000136","article-title":"Use of Smartphones as adjuvant tools for cervical cancer screening in low-resource settings","volume":"19","author":"Ricard-Gauthier","year":"2015","journal-title":"J Low Genit Tract Dis"},{"key":"2025121602243053000_12.12.e057234.22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1017\/S0266462318000260","article-title":"Performance of smartphone-based digital images for cervical cancer screening in a low-resource context","volume":"34","author":"Tran","year":"2018","journal-title":"Int J Technol Assess Health Care"},{"key":"2025121602243053000_12.12.e057234.23","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2147\/IJWH.S136351","article-title":"Cervical cancer screening in low-resource settings: a smartphone image application as an alternative to colposcopy","volume":"9","author":"Gallay","year":"2017","journal-title":"Int J Womens Health"},{"key":"2025121602243053000_12.12.e057234.24","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-052504"},{"key":"2025121602243053000_12.12.e057234.25","doi-asserted-by":"crossref","unstructured":"Fouogue J , Sando Z , Fouelifack F , et al . Report of the 7th international workshop on colposcopy, screening and prevention of cervical cancer, Douala, Cameroon, March 30 - 31 and April 1st 2016. Int J Reprod Contracept Obstet Gynecol 2016:3269\u201374.doi:10.18203\/2320-1770.ijrcog20163033","DOI":"10.18203\/2320-1770.ijrcog20163033"},{"key":"2025121602243053000_12.12.e057234.26","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1159\/000477556","article-title":"The Bethesda system for reporting cervical cytology: a historical perspective","volume":"61","author":"Nayar","year":"2017","journal-title":"Acta Cytol"},{"key":"2025121602243053000_12.12.e057234.27","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/cam4.1089","article-title":"Cervical cancer screening in a low-resource setting: a pilot study on an HPV-based screen-and-treat approach","volume":"6","author":"Kunckler","year":"2017","journal-title":"Cancer Med"},{"key":"2025121602243053000_12.12.e057234.28","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29085"},{"key":"2025121602243053000_12.12.e057234.29","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1097\/01.aids.0000432472.92120.1b","article-title":"Comparing Papanicolau smear, visual inspection with acetic acid and human papillomavirus cervical cancer screening methods among HIV-positive women by immune status and antiretroviral therapy","volume":"27","author":"Chung","year":"2013","journal-title":"AIDS"},{"key":"2025121602243053000_12.12.e057234.30","doi-asserted-by":"crossref","DOI":"10.3390\/v13122454","article-title":"Prevalence and distribution of HPV genotypes in immunosuppressed patients in Lorraine region","volume":"13","author":"Boudes","year":"2021","journal-title":"Viruses"},{"key":"2025121602243053000_12.12.e057234.31","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2147\/IJWH.S142911","article-title":"Efficacy of thermoablation in treating cervical precancerous lesions in a low-resource setting","volume":"9","author":"Tran","year":"2017","journal-title":"Int J Womens Health"},{"key":"2025121602243053000_12.12.e057234.32","doi-asserted-by":"crossref","DOI":"10.1186\/s12905-016-0355-x","article-title":"Feasibility of thermocoagulation in a screen-and-treat approach for the treatment of cervical precancerous lesions in sub-Saharan Africa","volume":"17","author":"Viviano","year":"2017","journal-title":"BMC Womens Health"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2021-057234","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T10:24:40Z","timestamp":1765880680000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2021-057234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":32,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12,22]]},"published-print":{"date-parts":[[2022,12]]}},"alternative-id":["10.1136\/bmjopen-2021-057234"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2021-057234","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12]]}}}